作者：马佳瑞，牛雅妮，万敬强，谢萍

单位：

1.宁夏医科大学临床医学院2.甘肃省人民医院心内一科

Units：

1.School of Clinical Medicine, Ningxia Medical University, Yinchuan 750004, China 2.First Department of Cardiology, Gansu Provincial Hospital, Lanzhou 730000, China

关键词：

肺肿瘤; 心血管疾病; 危险因素; 化疗药物;

Keywords：

Lung neoplasms; Cardiovascular diseases; Risk factors; Chemotherapy drugs

CLC：

DOI：

10.12114/j.issn.1008-5971.2022.00.303

Funds：

国家自然科学基金资助项目（81860047）；

摘要：

肺癌是中国死亡率最高的癌症，近年随着治疗方式的不断更新，肺癌患者的生存率得到提高，但肺癌幸存者罹患心血管疾病的风险不断增加。目前关于癌症患者心血管疾病发生风险的研究大多数集中于乳腺癌，但我国肺癌的发病率仅次于乳腺癌。本文就肺癌与心血管疾病的共同危险因素和共同病理生理机制、肺癌治疗导致的心血管疾病及肺癌患者心血管疾病的治疗做一总结，以期为肺癌患者的心脏管理提供参考，从而最大限度地提高肺癌幸存者的生活质量。

Abstract：

Lung cancer is the most deadly cancer in China. With the continuous update of treatment methods in recent years, the survival rate of lung cancer patients has been improved, but the risk of cardiovascular disease in cancer survivors has been increased. At present, most studies on cardiovascular disease risk of cancer patients focus on breast cancer, but the incidence of lung cancer in China is second only to breast cancer. This article summarizes the common risk factors and pathophysiological mechanism of lung cancer and cardiovascular disease of lung cancer patients, the cardiovascular disease caused by lung cancer treatment, and the treatment of cardiovascular disease of lung cancer patients, in order to provide reference suggestions for the cardiac management of lung cancer patients, and maximize the quality of life of lung cancer survivors.

ReferenceList：